USE OF ERYTHROPOIETIN FOR THE TREATMENT OF PRIMARY HEMO CHROMATES

• 1. 通过测定降钙素原水平对在原发性非感染性疾病患者中的抗生素治疗进行风险评估 [P] . 中国专利： CN102395888B . 2017.05.03
• 2. 通过测定降钙素原水平对在原发性非感染性疾病患者中的抗生素治疗进行风险评估 [P] . 中国专利： CN105334330A . 2016-02-17
• 3. PRIMARY COATING CHROMATE COMPOSITION FOR PRECOATED STEEL SHEET AND TREATMENT THEREOF [P] . 日本专利： JPH0693465A . 1994-04-05

  机译： 预涂钢板的主涂层铬酸盐成分及其处理

• 4. PRIMARY COATING CHROMATE COMPOSITION FOR PRECOATED STEEL SHEET AND TREATMENT THEREFOR [P] . 日本专利： JPH0693464A . 1994-04-05

  机译： 预涂钢板的主要涂层铬酸盐成分及其处理方法

• 5. PRIMARY COATING CHROMATE COMPOSITION FOR PRECOATED STEEL SHEET AND TREATMENT THEREFOR [P] . 日本专利： JPH0693466A . 1994-04-05

  机译： 预涂钢板的主要涂层铬酸盐成分及其处理方法

• 1. OUR EXPERIENCE FOR THE TREATMENT OF SPONTANEOUS HEMO-PNEUMOTHORAX [J] . 朱恩良, 李国庆, 隆桂麟, 上海交通大学学报：医学英文版 . 1993,第001期
• 2. Individualized Treatment and Palliative Care for A 90-Year-Old Patient with Primary Gastric Diffuse Large-B Cell Lymphoma: 4 Year Follow-up and Inspiration [J] . Yanjie Cao, Jingqi Duan, Lifang Liu, 中国医学科学杂志（英文版） . 2021,第001期
• 3. Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo(2)study) [J] . Chalopin Thomas, Vallet Nicolas, Arbion Flavie, Annals of hematology . 2019,第10期
• 4. Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation. [J] . Temkin SM, Hellmann M, Serur E, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2006,第5期
• 5. Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment | Haematologica [J] . Angel F. Remacha, Beatriz Arrizabalaga, Javier Bueno, Haematologica . 2010,第2期
• 6. Comparison of Chromate and Chromate-free Pre-Treatments of Aluminium AA 2024, unclad [C] . G. Eich, B. Neumann, K. Kranzeder European corrosion congress . 2012
• 7. Activities of minimal erythropoietin receptor tyrosine 343 and phosphotyrosine-null forms in primary murine erythroid progenitor cells. [D] . Miller, Christopher P. 2002
• 8. Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment [O] . Angel F. Remacha, Beatriz Arrizabalaga, Javier Bueno, 2010
• 9. Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment [O] . Remacha, Angel F., Arrizabalaga, Beatriz, Bueno, Javier, 2010
• 10. Closure plan for the Test Area North-726 chromate water storage and Test Area North-726A chromate treatment units. Revision 1 [R] . Smith, P J, Van Brunt, KM 1992

• 1. Post treatment of silane and cerium salt as chromate replacers on galvanized steel [J] . 孔纲 ,卢锦堂 ,吴海江 . 稀土学报：英文版 . 2009,第1期
• 2. NON-CHROMATE CONVERSION COATING TREATMENT FOR MAGNESIUM ALLOY [J] . A.P.Zeng Y.Xue Y.F.Qian and Z.J.Wang Shanghai Institute of MetallurgyThe Chinese Academy of Sciences Shanghai 200050 China . 金属学报：英文版 . 1999,第5期
• 3. Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient:A case report [J] . Wei-Hong Yu ,Xie-Jia Li ,Fang Yuan . 世界临床病例杂志 . 2020,第023期
• 4. 补肾健脾方配合促红细胞生成素治疗低中危骨髓增生异常综合征86例 [C] . 刘驰 ,张姗姗 ,肖海燕 . 第十一届全国中西医结合血液学学术会议暨第二届中西医结合血液学高峰论坛 . 2014
• 5. IL--34在原发性肝癌组织中表达及在原位肝癌模型中的作用 [A] . 殷剑 . 2018